VectivBio
VECT
$16.85
Share price
0.00%
Change (1 day)
206.92%
Change (1 year)
Categories
VectivBio (VECT) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $39.23 M
According to VectivBio's latest financial reports the company's total liabilities are $39.23 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
VectivBio - Total liabilities on balance sheet (from 2020 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $39.23 M | 91.07% |
| 2021-12-31 | $20.53 M | -46.43% |
| 2020-12-31 | $38.32 M | 10.63% |
| 2019-12-31 | $34.64 M | 175.46% |
| 2018-12-31 | $12.57 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -93.12% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 211.00% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 6,309.27% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 1,897.48% | Jersey |